Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1978 Dec;34(3):338–346.

Discordance of Epstein–Barr Virus (EBV) specific humoral and cellular immunity in patients with malignant lymphomas: elevated antibody titres and lowered in vitro lymphocyte reactivity

CHR H H Ten Napel, T H The, J Van Egten-Bijker, G C De Gast, M R Halie, M M A C Langenhuysen
PMCID: PMC1537550  PMID: 217561

Abstract

The relationship between specific viral cellular and humoral immunity to the Epstein–Barr Virus (EBV) was investigated in thirty-one untreated patients with malignant lymphoma (ML) and sex- and age-matched controls. In vitro reactivity of peripheral blood lymphocytes to heatinactivated purified EBV, in an optimal stimulating concentration, was measured with 3H-thymidine uptake. In seropositive individuals EBV lymphocyte reactivity was positively related to EBV virus capsid antibody titres. In contrast, ML patients, especially those with Hodgkin's disease, showed markedly (P<0·01) impaired EBV lymphocyte reactivity in association with raised EBV virus capsid antibody titres. The disturbance of EBV lymphocyte reactivity was not related to the impairment of non-specific lymphocyte reactivity to mitogens and recall antigens in these patients. This study supports the hypothesis that depressed cellular immunity may cause raised EBV antibodies in ML, especially in Hodgkin's disease.

Full text

PDF
338

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. AISENBERG A. C., LESKOWITZ S. Antibody formation in Hodgkin's disease. N Engl J Med. 1963 Jun 6;268:1269–1272. doi: 10.1056/NEJM196306062682304. [DOI] [PubMed] [Google Scholar]
  2. De Gast G. C., Halie M. R. Relation of cell-mediated immunity to staging, histology and prognosis in untreated patients with Hodgkin's disease. Neth J Med. 1976;19(4-5):196–200. [PubMed] [Google Scholar]
  3. Dumont J., Liabeuf A., Henle W., Feingold N., Kourilsky F. M. Anti-EBV antibody titers in non-Hodgkin lymphomas. Int J Cancer. 1976 Jul 15;18(1):14–23. doi: 10.1002/ijc.2910180104. [DOI] [PubMed] [Google Scholar]
  4. Eltringham J. R., Kaplan H. S. Impaired delayed-hypersensitivity responses in 154 patients with untreated Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:107–115. [PubMed] [Google Scholar]
  5. Fernandez L. A., MacSween J. M., Langley G. R. Lymphocyte responses to phytohaemagglutinin: age-related effects. Immunology. 1976 Oct;31(4):583–587. [PMC free article] [PubMed] [Google Scholar]
  6. Gast G. C., Halie M. R., Nieweg H. O. Immunological responsiveness against two primary antigens in untreated patients with Hodgkin's disease. Eur J Cancer. 1975 Apr;11(4):217–224. doi: 10.1016/0014-2964(75)90001-8. [DOI] [PubMed] [Google Scholar]
  7. Gerber P., Lucas S. J. In vitro stimulation of human lymphocytes by Epstein-Barr virus. Cell Immunol. 1972 Oct;5(2):318–324. doi: 10.1016/0008-8749(72)90057-3. [DOI] [PubMed] [Google Scholar]
  8. Han T., Sokal J. E. Lymphocyte response to phytohemagglutinin in Hodgkin's disease. Am J Med. 1970 Jun;48(6):728–734. doi: 10.1016/s0002-9343(70)80008-0. [DOI] [PubMed] [Google Scholar]
  9. Henle G., Henle W., Clifford P., Diehl V., Kafuko G. W., Kirya B. G., Klein G., Morrow R. H., Munube G. M., Pike P. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. J Natl Cancer Inst. 1969 Nov;43(5):1147–1157. [PubMed] [Google Scholar]
  10. Henle G., Henle W., Diehl V. Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis. Proc Natl Acad Sci U S A. 1968 Jan;59(1):94–101. doi: 10.1073/pnas.59.1.94. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Henle G., Henle W. Immunofluorescence in cells derived from Burkitt's lymphoma. J Bacteriol. 1966 Mar;91(3):1248–1256. doi: 10.1128/jb.91.3.1248-1256.1966. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Henle W., Henle G. Epstein-Barr virus-related serology in Hodgkin's disease. Natl Cancer Inst Monogr. 1973 May;36:79–84. [PubMed] [Google Scholar]
  13. Hesse J., Levine P. H., Ebbesen P., Connelly R. R., Mordhorst C. H. A case control study on immunity to two Epstein-Barr virus-associated antigens, and to herpes simplex virus and adenovirus in a population-based group of patients with Hodgkin's disease in Denmark, 1971-73. Int J Cancer. 1977 Jan;19(1):49–58. doi: 10.1002/ijc.2910190108. [DOI] [PubMed] [Google Scholar]
  14. Hilgers F., Hilgers J. An immunofluorescence technique with counterstain on fixed cells for the detection of antibodies to human herpesviruses; antibody patterns in patients with Hodgkin's disease and nasopharyngeal carcinoma. Intervirology. 1976;7(6):309–327. doi: 10.1159/000149972. [DOI] [PubMed] [Google Scholar]
  15. Janossy G., Greaves M. F. Lymphocyte activation. I. Response of T and B lymphocytes to phytomitogens. Clin Exp Immunol. 1971 Oct;9(4):483–498. [PMC free article] [PubMed] [Google Scholar]
  16. Johansson B., Killander D., Holm G., Mellstedt H., Henle G., Henle W., Klein G., Söderberg G. Epstein-Barr virus (EBV)-associated antibody patterns in relation to the deficiency of cell-mediated immunity in patients with Hodgkin's disease. IARC Sci Publ. 1975;(11 Pt 2):237–247. [PubMed] [Google Scholar]
  17. Johansson B., Klein G., Henle W., Henle G. Epstein-Barr virus (EBV)-associated antibody patterns in malignant lymphoma and leukemia. I. Hodgkin's disease. Int J Cancer. 1970 Nov 15;6(3):450–462. doi: 10.1002/ijc.2910060316. [DOI] [PubMed] [Google Scholar]
  18. Klein G., Giovanella B. C., Lindahl T., Fialkow P. J., Singh S., Stehlin J. S. Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx. Proc Natl Acad Sci U S A. 1974 Dec;71(12):4737–4741. doi: 10.1073/pnas.71.12.4737. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Klein G., Sugden B., Leibold W., Menezes J. Infection of EBV-genome-negative and -positive human lymphoblastoid cell lines with biologically different preparations of EBV. Intervirology. 1974;3(4):232–244. doi: 10.1159/000149760. [DOI] [PubMed] [Google Scholar]
  20. Langenhuysen M. M., Cazemier T., Houwen B., Brouwers T. M., Halie M. R., The T. H., Nieweg H. O. Antibodies to Epstein-Barr virus, cytomegalovirus, and Australia antigen in Hodgkin's disease. Cancer. 1974 Aug;34(2):262–267. doi: 10.1002/1097-0142(197408)34:2<262::aid-cncr2820340207>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  21. Langenhuysen M. M., The T. H., Halie M. R., De Gast G. C. Hodgkin's disease and herpes viruses. Neth J Med. 1976;19(4-5):185–190. [PubMed] [Google Scholar]
  22. Levine P. H., Merrill D. A., Bethlenfalvay N. C., Dabich L., Stevens D. A., Waggoner D. E. A longitudinal comparison of antibodies to Epstein-Barr virus and clinical parameters in chronic lymphocytic leukemia and chronic myelocytic leukemia. Blood. 1971 Oct;38(4):479–484. [PubMed] [Google Scholar]
  23. Levy R., Kaplan H. S. Impaired lymphocyte function in untreated Hodgkin's disease. N Engl J Med. 1974 Jan 24;290(4):181–186. doi: 10.1056/NEJM197401242900402. [DOI] [PubMed] [Google Scholar]
  24. Moller-Larsen A., Andersen H. K., Heron I., Sarov I. In vitro stimulation of human lymphocytes by purified cytomegalovirus. Intervirology. 1975;6(4-5):249–257. doi: 10.1159/000149479. [DOI] [PubMed] [Google Scholar]
  25. Porter D. D., Wimberly I., Benyesh-Melnick M. Prevalence of antibodies to EB virus and other herpesviruses. JAMA. 1969 Jun 2;208(9):1675–1679. [PubMed] [Google Scholar]
  26. Rasmussen L. E., Jordan G. W., Stevens D. A., Merigan T. C. Lymphocyte interferon production and transformation after Herpes simplex infections in humans. J Immunol. 1974 Feb;112(2):728–736. [PubMed] [Google Scholar]
  27. Roberts-Thomson I. C., Whittingham S., Youngchaiyud U., Mackay I. R. Ageing, immune response, and mortality. Lancet. 1974 Aug 17;2(7877):368–370. doi: 10.1016/s0140-6736(74)91755-3. [DOI] [PubMed] [Google Scholar]
  28. The T. H., Andersen H. K., Spencer E. S., Klein G. Antibodies against cytomegalovirus-induced early antigens (CMV-EA) in immunosuppressed renal-allograft recipients. Clin Exp Immunol. 1977 Jun;28(3):502–505. [PMC free article] [PubMed] [Google Scholar]
  29. The T. H., Feltkamp T. E. Conjugation of fluorescein isothiocyanate to antibodies. II. A reproducible method. Immunology. 1970 Jun;18(6):875–881. [PMC free article] [PubMed] [Google Scholar]
  30. zur Hausen H., Schulte-Holthausen H., Klein G., Henle W., Henle G., Clifford P., Santesson L. EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx. Nature. 1970 Dec 12;228(5276):1056–1058. doi: 10.1038/2281056a0. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES